BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29100701)

  • 41. Four-dimensional treatment planning in layer-stacking boost irradiation for carbon-ion pancreatic therapy.
    Mori S; Shinoto M; Yamada S
    Radiother Oncol; 2014 May; 111(2):258-63. PubMed ID: 24746568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Photons, protons or carbon ions for stage I non-small cell lung cancer - Results of the multicentric ROCOCO in silico study.
    Wink KCJ; Roelofs E; Simone CB; Dechambre D; Santiago A; van der Stoep J; Dries W; Smits J; Avery S; Ammazzalorso F; Jansen N; Jelen U; Solberg T; de Ruysscher D; Troost EGC
    Radiother Oncol; 2018 Jul; 128(1):139-146. PubMed ID: 29545019
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Consequences of anatomic changes and respiratory motion on radiation dose distributions in conformal radiotherapy for locally advanced non-small-cell lung cancer.
    Britton KR; Starkschall G; Liu H; Chang JY; Bilton S; Ezhil M; John-Baptiste S; Kantor M; Cox JD; Komaki R; Mohan R
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):94-102. PubMed ID: 18929448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of image-guidance frequency on geometric accuracy and setup margins in radiotherapy for locally advanced lung cancer.
    Higgins J; Bezjak A; Hope A; Panzarella T; Li W; Cho JB; Craig T; Brade A; Sun A; Bissonnette JP
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1330-7. PubMed ID: 20643515
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Respiratory gating for proton beam scanning versus photon 3D-CRT for breast cancer radiotherapy.
    Flejmer AM; Edvardsson A; Dohlmar F; Josefsson D; Nilsson M; Witt Nyström P; Dasu A
    Acta Oncol; 2016 May; 55(5):577-83. PubMed ID: 27027913
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interfractional dose variations in intensity-modulated radiotherapy with breath-hold for pancreatic cancer.
    Nakamura M; Shibuya K; Nakamura A; Shiinoki T; Matsuo Y; Nakata M; Sawada A; Mizowaki T; Hiraoka M
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1619-26. PubMed ID: 21477941
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dosimetric impact of 4DCT artifact in carbon-ion scanning beam treatment: Worst case analysis in lung and liver treatments.
    Mori S; Kumagai M; Karube M; Yamamoto N
    Phys Med; 2016 Jun; 32(6):787-94. PubMed ID: 27184551
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Three-dimensional radiation treatment planning study for patients with carcinoma of the lung.
    Graham MV; Matthews JW; Harms WB; Emami B; Glazer HS; Purdy JA
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):1105-17. PubMed ID: 8083080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of organ motion on proton prostate treatments, as determined from analysis of daily CT imaging for patient positioning.
    Maeda Y; Sato Y; Shibata S; Bou S; Yamamoto K; Tamamura H; Fuwa N; Takamatsu S; Sasaki M; Tameshige Y; Kume K; Minami H; Saga Y; Saito M
    Med Phys; 2018 May; 45(5):1844-1856. PubMed ID: 29574901
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Scope and method of image registration and clinical target volume margin for central-type non-small cell lung cancer in image-guided radiotherapy].
    Sun W; Song L; Ma J; Zhang Y; Zhang L; Gao Y; Ai T
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Feb; 38(2):132-7. PubMed ID: 23456071
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Dose Escalation Clinical Trial of Single-Fraction Carbon Ion Radiotherapy for Peripheral Stage I Non-Small Cell Lung Cancer.
    Yamamoto N; Miyamoto T; Nakajima M; Karube M; Hayashi K; Tsuji H; Tsujii H; Kamada T; Fujisawa T
    J Thorac Oncol; 2017 Apr; 12(4):673-680. PubMed ID: 28007628
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence, risk factors, and dose-volume relationship of radiation-induced rib fracture after carbon ion radiotherapy for lung cancer.
    Abe T; Shirai K; Saitoh J; Ebara T; Shimada H; Tashiro M; Okano N; Ohno T; Nakano T
    Acta Oncol; 2016; 55(2):163-6. PubMed ID: 26399488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Phase I Study of Hypofractionated Carbon-ion Radiotherapy for Stage III Non-small Cell Lung Cancer.
    Saitoh JI; Shirai K; Abe T; Kubo N; Ebara T; Ohno T; Minato K; Saito R; Yamada M; Nakano T;
    Anticancer Res; 2018 Feb; 38(2):885-891. PubMed ID: 29374716
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
    Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in the radiological depth correlate with dosimetric deterioration in particle therapy for stage I NSCLC patients under high frequency jet ventilation.
    Santiago A; Fritz P; Mühlnickel W; Engenhart-Cabillic R; Wittig A
    Acta Oncol; 2015; 54(9):1631-7. PubMed ID: 26228661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carbon-ion re-irradiation for recurrences after initial treatment of stage I non-small cell lung cancer with carbon-ion radiotherapy.
    Karube M; Yamamoto N; Tsuji H; Kanematsu N; Nakajima M; Yamashita H; Nakagawa K; Kamada T
    Radiother Oncol; 2017 Oct; 125(1):31-35. PubMed ID: 28784437
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interfractional positional variability of fiducial markers and primary tumors in locally advanced non-small-cell lung cancer during audiovisual biofeedback radiotherapy.
    Roman NO; Shepherd W; Mukhopadhyay N; Hugo GD; Weiss E
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1566-72. PubMed ID: 22391105
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].
    Gong HY; Yu JM; Fu Z; Li BS; Li JB; Liu TH
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):54-7. PubMed ID: 16737623
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of [18F]fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non-small-cell lung cancer: a prospective study.
    Kolodziejczyk M; Kepka L; Dziuk M; Zawadzka A; Szalus N; Gizewska A; Bujko K
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1008-14. PubMed ID: 20656419
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Robustness of target dose coverage to motion uncertainties for scanned carbon ion beam tracking therapy of moving tumors.
    Eley JG; Newhauser WD; Richter D; Lüchtenborg R; Saito N; Bert C
    Phys Med Biol; 2015 Feb; 60(4):1717-40. PubMed ID: 25650520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.